Measurement of plasma glucagon in humans - a shift in the performance of a current commercially available RIA kit.

Wu, T.; Rayner, C.K.; Jones, K.L.; Horowitz, M.; Feinle-Bisset, C.; Standfield, S.D.; Xie, C.; Deacon, C.F.; Holst, J.J.; Wewer Albrechtsen, N.J.

doi:10.1111/dom.14673

Measurement of plasma glucagon in humans - a shift in the performance of a current commercially available RIA kit.

Date

2022

Authors

Wu, T.

Rayner, C.K.

Jones, K.L.

Horowitz, M.

Feinle-Bisset, C.

Standfield, S.D.

Xie, C.

Deacon, C.F.

Holst, J.J.

Wewer Albrechtsen, N.J.

Type:

Journal article

Citation

Diabetes, Obesity and Metabolism, 2022; 24(6):1182-1184

Statement of Responsibility

Tongzhi Wu, Christopher K. Rayner, Karen L. Jones, Michael Horowitz, Christine Feinle-Bisset, Scott D. Standfield, Cong Xie, Carolyn F. Deacon, Jens J. Holst, Nicolai J. Wewer Albrechtsen

DOI

10.1111/dom.14673

Abstract

Abstract unavailable.

Description

Letter to Editor

Rights

Published Version

https://doi.org/10.1111/dom.14673

Persistent link to this record

https://hdl.handle.net/2440/145903

Full item page

Measurement of plasma glucagon in humans - a shift in the performance of a current commercially available RIA kit.

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record